- 期刊
Switching from Ticagrelor to Clopidogrel in Asian Patients with ST-Elevated Myocardial Infarction - A Time Dependent Analysis Study
摘要
Background: Ticagrelor is initially prescribed after an ST-elevated myocardial infarction (STEMI) and this may be followed by a switch to clopidogrel. However, studies involving antiplatelet switching have been conflicting and only assessed at a specific switch point. The objective of this study was to investigate switching from ticagrelor to clopidogrel in an Asian population, after accounting for various switch points as in a real-world environment. Methods: A retrospective cohort of 349 STEMI patients started on ticagrelor and aspirin were followed-up for 1 year after a percutaneous coronary intervention that was performed between June 2014 and November 2016. Patients who switched to clopidogrel were compared with those who remained on ticagrelor. Outcomes measured were major adverse cardiac and cerebrovascular events (MACCEs) and clinically significant bleeding (CSB). Cox regression analysis with switch status as a time-dependent covariate was performed. Results: The switched group was not associated with MACCEs or CSB [10.0% vs. 13.8%; hazard ratio (HR) = 0.484; 95% confidence interval (CI): 0.196- 1.191; p = 0.114]. There was also no significant difference when MACCEs were analyzed alone (2.3% vs. 7.7%; HR = 0.518; 95% CI: 0.137-1.957; p = 0.332). For CSB, the switched group was less likely to have an event (7.8% vs. 8.5%; HR = 0.298; 95% CI: 0.091-0.982; p = 0.047). Conclusions: This study showed no significant difference between staying on ticagrelor and switching to clopidogrel. Switching might decrease the incidence of CSB. De-escalation from ticagrelor to clopidogrel could translate to cost savings for Asian patients without compromising safety and efficacy.
延伸閱讀
- 楊馥鴻（2005）。A Study of Aspirin and Clopidogrel Resistance in the Patients with Cardiovascular Disease〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-2903200614043746
- Yuan, S. M. (1998). A Generalized Consideration of Myocardial Preservation With Cold Crystalloid Versus Warm Blood Cardioplegia in Heart Valve Replacement. The Kaohsiung Journal of Medical Sciences, 14(5), 266-273. https://doi.org/10.6452/KJMS.199805.0266
- Liu, P. Y., Tsai, T. N., Lin, C. S., Lin, W. Y., Cheng, C. C., Lin, W. S., Hsu, C. H., Liou, J. T., Cheng, S. M., Lin, G. M., & Wu, C. H. (2015). Clinical and Prognostic Correlates of ST-Elevation Myocardial Infarction Patients with Normal Coronary Angiography. Journal of Medical Sciences, 35(4), 135-140. https://doi.org/10.4103/1011-4564.163820
- Lu, Y. Y., Wang, C. L., Chang, S. H., Hsiao, F. C., Huang, Y. C., Huang, Y. T., Liao, T. W., & Chu, P. H. (2022). Dual versus Single Antiplatelet Therapy in Medically Treated Acute Myocardial Infarction Patients with Baseline Thrombocytopenia - Insights from a Multi-Institute Cohort Study. Acta Cardiologica Sinica, 38(4), 443-454. https://doi.org/10.6515/ACS.202207_38(4).20220109A
- Mar, G. Y., Ridderstråle, W., Wei, J., & Liu, C. P. (2020). Safety and Cumulative Incidence of Major Cardiovascular Events with Ticagrelor in Taiwanese Patients with Non-ST-Segment Elevation Myocardial Infarction: A 12-Month, Prospective, Phase IV, Multicenter, Single-Arm Study. Acta Cardiologica Sinica, 36(3), 195-206. https://doi.org/10.6515/ACS.202005_36(3).20191007B